Incyte (INCY) - Stock price history

Stock price history of Incyte from 1993 to 2025

Annual Stock Price Performance

Year	Performance
2025	36.88%
2024	5.53%
2023	-21.07%
2022	8.58%
2021	-15.10%
2020	1.17%
2019	37.38%
2018	-36.97%
2017	-7.44%
2016	-2.95%
2015	47.03%
2014	42.71%
2013	197.82%
2012	10.81%
2011	-9.14%
2010	74.32%
2009	136.62%
2008	-62.02%
2007	66.94%
2006	9.36%
2005	-44.61%
2004	46.48%
2003	39.59%
2002	-76.49%
2001	-13.84%
2000	-44.51%
1999	62.16%
1998	-12.57%
1997	76.47%
1996	83.11%
1995	83.49%
1994	58.57%
1993	20.00%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Amgen AMGN	NZ$543.12	0.49%	🇺🇸 USA
Ligand Pharmaceuticals LGND	NZ$316.92	-0.97%	🇺🇸 USA
Eli Lilly LLY	NZ$1,711	1.16%	🇺🇸 USA
Pfizer PFE	NZ$44.40	1.78%	🇺🇸 USA
Geron GERN	NZ$2.20	4.07%	🇺🇸 USA
Ardelyx ARDX	NZ$10.19	2.07%	🇺🇸 USA
Novartis NVS	NZ$225.92	0.14%	🇨🇭 Switzerland
AVEO Oncology AVEO	NZ$25.83	0.00%	🇺🇸 USA
CTI BioPharma CTIC	NZ$15.65	0.00%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Incyte (INCY)